Author Question: Prescription treatments for burn patients include all of the following except: a. vitamin C and Zn. ... (Read 20 times)

wrbasek0

  • Hero Member
  • *****
  • Posts: 560
Prescription treatments for burn patients include all of the following except:
 a. vitamin C and Zn.
  b. megace.
  c. oxandrolone.
  d. silver nitrate.

Question 2

Regarding enteral nutrition and the burn patient, which of the following statements is true?
 a. Small bowel feedings may be favored due to the presence of ileus.
  b. If the patient can tolerate an oral diet, EN is not indicated.
  c. Formula should be initiated at a very low rate due to hemodynamic instability.
  d. There are no benefits to early initiation of EN.



shailee

  • Sr. Member
  • ****
  • Posts: 392
Answer to Question 1

b

Answer to Question 2

a



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Though the United States has largely rejected the metric system, it is used for currency, as in 100 pennies = 1 dollar. Previously, the British currency system was used, with measurements such as 12 pence to the shilling, and 20 shillings to the pound.

Did you know?

As many as 20% of Americans have been infected by the fungus known as Histoplasmosis. While most people are asymptomatic or only have slight symptoms, infection can progress to a rapid and potentially fatal superinfection.

Did you know?

The Centers for Disease Control and Prevention has released reports detailing the deaths of infants (younger than 1 year of age) who died after being given cold and cough medications. This underscores the importance of educating parents that children younger than 2 years of age should never be given over-the-counter cold and cough medications without consulting their physicians.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library